CD4 and neoplasm: Graphical Abstract: We identified a novel population of CD4 tumour‐infiltrating lymphocytes (TILs) in BLCA, defined as the co‐expression of PD‐1 and CD200, which may help to explore the mechanisms of tumour progression and immunotherapy resistance.